Skip to main content

Advertisement

Log in

Non-Invasive Intravital Imaging of siRNA-Mediated Mutant Keratin Gene Repression in Skin

  • Research Article
  • Published:
Molecular Imaging and Biology Aims and scope Submit manuscript

Abstract

Purpose

Small interfering RNAs (siRNAs) specifically and potently inhibit target gene expression. Pachyonychia congenita (PC) is a skin disorder caused by mutations in genes encoding keratin (K) 6a/b, K16, and K17, resulting in faulty intermediate filaments. A siRNA targeting a single nucleotide, PC-relevant mutation inhibits K6a expression and has been evaluated in the clinic with encouraging results.

Procedures

To better understand the pathophysiology of PC, and develop a model system to study siRNA delivery and visualize efficacy in skin, wild type (WT) and mutant K6a complementary DNAs (cDNAs) were fused to either enhanced green fluorescent protein or tandem tomato fluorescent protein cDNA to allow covisualization of mutant and WT K6a expression in mouse footpad skin using a dual fluorescence in vivo confocal imaging system equipped with 488 and 532 nm lasers.

Results

Expression of mutant K6a/reporter resulted in visualization of keratin aggregates, while expression of WT K6a/reporter led to incorporation into filaments. Addition of mutant K6a-specific siRNA resulted in inhibition of mutant, but not WT, K6a/reporter expression.

Conclusions

Intravital imaging offers subcellular resolution for tracking functional activity of siRNA in real time and enables detailed analyses of therapeutic effects in individual mice to facilitate development of nucleic acid-based therapeutics for skin disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Zhou Y, Zhang C, Liang W (2014) Development of RNAi technology for targeted therapy—a track of siRNA based agents to RNAi therapeutics. J Control Release 193:270–281

    Article  CAS  PubMed  Google Scholar 

  2. Haussecker D (2014) Current issues of RNAi therapeutics delivery and development. J control Release : Off J Control Release Soc 195:49–54

    Article  CAS  Google Scholar 

  3. Kubowicz P, Zelaszczyk D, Pekala E (2013) RNAi in clinical studies. Curr Med Chem 20:1801–1816

    Article  CAS  PubMed  Google Scholar 

  4. Leachman SA, Hickerson RP, Schwartz ME et al (2010) First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. Mol Ther 18:442–446

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Leachman SA, Hickerson RP, Hull PR et al (2008) Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenita. J Dermatol Sci 51:151–157

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Gonzalez-Gonzalez E, Kim YC, Speaker TJ et al (2011) Visualization of plasmid delivery to keratinocytes in mouse and human epidermis. Sci Rep 1:158

    PubMed Central  PubMed  Google Scholar 

  7. Leachman SA, Kaspar RL, Fleckman P et al (2005) Clinical and pathological features of pachyonychia congenita. J Investig Dermatol Symp Proc 10:3–17

    Article  CAS  PubMed  Google Scholar 

  8. McLean WH, Hansen CD, Eliason MJ, Smith FJ (2011) The phenotypic and molecular genetic features of pachyonychia congenita. J Investig Dermatol 131:1015–1017

    Article  CAS  PubMed  Google Scholar 

  9. Smith FJD, Hansen CD, Hull PR et al (2014) Pachyonychia congenita. GeneReviews:http://www.ncbi.nlm.nih.gov/books/NBK1280/

  10. Cao YA, Hickerson RP, Seegmiller BL et al (2015) Gene expression profiling in pachyonychia congenita skin. J Dermatol Sci 77:156–165

    Article  CAS  PubMed  Google Scholar 

  11. Hickerson RP, Smith FJ, Reeves RE et al (2008) Single-nucleotide-specific siRNA targeting in a dominant-negative skin model. J Investig Dermatol 128:594–605

    Article  CAS  PubMed  Google Scholar 

  12. Hickerson RP, Leachman SA, Pho LN et al (2011) Development of quantitative molecular clinical end points for siRNA clinical trials. J Investig Dermatol 131:1029–1036

    Article  CAS  PubMed  Google Scholar 

  13. Ra H, Piyawattanametha W, Gonzalez-Gonzalez E et al (2011) In vivo imaging of human and mouse skin with a handheld dual-axis confocal fluorescence microscope. J Investig Dermatol 131:1061–1066

    Article  CAS  PubMed  Google Scholar 

  14. Hickerson RP, Gonzalez-Gonzalez E, Vlassov AV et al (2012) Intravital fluorescence imaging of small interfering RNA-mediated gene repression in a dual reporter melanoma xenograft model. Nucl Acid Ther 22:438–443

    CAS  Google Scholar 

  15. Diaconeasa A, Boda D, Neagu M et al (2011) The role of confocal microscopy in the dermato-oncology practice. J Med Life 4:63–74

    PubMed Central  CAS  PubMed  Google Scholar 

  16. Calzavara-Pinton P, Longo C, Venturini M, Sala R, Pellacani G (2008) Reflectance confocal microscopy for in vivo skin imaging. Photochem Photobiol 84:1421–1430

    Article  CAS  PubMed  Google Scholar 

  17. Hickerson RP, Vlassov AV, Wang Q et al (2008) Stability study of unmodified siRNA and relevance to clinical use. Oligonucleotides 18:345–354

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Lara MF, Gonzalez-Gonzalez E, Speaker TJ et al (2012) Inhibition of CD44 gene expression in human skin models, using self-delivery short interfering RNA administered by dissolvable microneedle arrays. Hum Gene Ther 23:816–823

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Smith FJ, Hickerson RP, Sayers JM et al (2008) Development of therapeutic siRNAs for pachyonychia congenita. J Investig Dermatol 128:50–58

    Article  CAS  PubMed  Google Scholar 

  20. Wang Q, Ilves H, Chu P et al (2007) Delivery and inhibition of reporter genes by small interfering RNAs in a mouse skin model. J Investig Dermatol 127:2577–2584

    Article  CAS  PubMed  Google Scholar 

  21. Gonzalez-Gonzalez E, Ra H, Hickerson RP et al (2009) siRNA silencing of keratinocyte-specific GFP expression in a transgenic mouse skin model. Gene Ther 16:963–972

    Article  CAS  PubMed  Google Scholar 

  22. Hickerson RP, Wey WC, Rimm DL et al (2013) Gene silencing in skin after deposition of self-delivery siRNA with a motorized microneedle array device. Mol Ther Nucl Acids 2, e129

    Article  Google Scholar 

  23. Schwarz DS, Ding H, Kennington L et al (2006) Designing siRNA that distinguish between genes that differ by a single nucleotide. PLoS Genet 2, e140

    Article  PubMed Central  PubMed  Google Scholar 

  24. Allen EH, Atkinson SD, Liao H et al (2013) Allele-specific siRNA silencing for the common keratin 12 founder mutation in Meesmann epithelial corneal dystrophy. Invest Ophthalmol Vis Sci 54:494–502

    Article  CAS  PubMed  Google Scholar 

  25. Ohnishi Y, Tamura Y, Yoshida M, Tokunaga K, Hohjoh H (2008) Enhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi. PLoS One 3, e2248

    Article  PubMed Central  PubMed  Google Scholar 

  26. Leslie Pedrioli DM, Fu DJ, Gonzalez-Gonzalez E et al (2012) Generic and personalized RNAi-based therapeutics for a dominant-negative epidermal fragility disorder. J Investig Dermatol 132:1627–1635

    Article  CAS  PubMed  Google Scholar 

  27. Hegde V, Hickerson RP, Nainamalai S et al (2014) In vivo gene silencing following non-invasive siRNA delivery into the skin using a novel topical formulation. J Control Release 196:355–362

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Gonzalez-Gonzalez E, Speaker TJ, Hickerson RP et al (2010) Silencing of reporter gene expression in skin using siRNAs and expression of plasmid DNA delivered by a soluble protrusion array device (PAD). Mol Ther 18:1667–1674

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Steinstraesser L, Lam MC, Jacobsen F et al (2014) Skin electroporation of a plasmid encoding hCAP-18/LL-37 host defense peptide promotes wound healing. Mol Ther 22:734–742

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Zheng D, Giljohann DA, Chen DL et al (2012) Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation. Proc Natl Acad Sci 109:11975–11980

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  31. Chen M, Zakrewsky M, Gupta V et al (2014) Topical delivery of siRNA into skin using SPACE-peptide carriers. J Control Release 179:33–41

    Article  PubMed Central  PubMed  Google Scholar 

  32. Cheng J, Syder AJ, Yu QC et al (1992) The genetic basis of epidermolytic hyperkeratosis: a disorder of differentiation-specific epidermal keratin genes. Cell 70:811–819

    Article  CAS  PubMed  Google Scholar 

  33. Irvine AD, McLean WH (1999) Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation. Br J Dermatol 140:815–828

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Conor Cox for his efforts in acquiring the confocal microscopy and fluorescent histological data. We also thank Robert Kaspar, Heini Ilves, and Jed Humphries for technical support and Andrea Burgon for administrative support. This work was supported by NIH grants R44AR056559 (RLK, CHC) and the Chambers Family Foundation (CHC).

Conflict of Interest

Roger Kaspar and Robyn Hickerson have patents issued and pending on using siRNA to treat PC and siRNA delivery technologies.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Roger L. Kaspar.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Supplementary Video 1

(Movie showing full dataset from Fig. 3.) Separate intradermal injections of distinct reporter expression plasmids to mouse footpads results in distinct subsets of keratinocytes that express each reporter protein. To determine if successive intradermal injections would result in delivery and expression of reporter genes in the same, or different, subsets of cells, two separate injections (12 h apart) of plasmids expressing differentially-labeled reporter proteins were performed. The expression construct pUBC-K6a(N171K)-tdTFP was injected into a mouse footpad at time 0. At 12 h, pUBC-K6a(WT)-EFGP was injected into the same footpad, as close to the original injection site as possible. The footpad skin was imaged at 36 h using the intravital scope. a Reflectance was used to visualize skin structure and create a reference image. Fluorescence using b 488 and c 532 nm lasers are d overlaid to show the subsets of cells expressing the reporter protein from each injection. (AVI 10221 kb)

Supplementary Video 2

As described in Fig. 4, mouse paws were imaged with the confocal imaging VivaScope. Movie shows all images collected every 2 μm from the skin surface to a depth of 130 μm. En face images using reflectance and green and red fluorescence from both paws are shown. Note that the left panel in (c) is reflectance microscopy to show general skin structure. (AVI 32240 kb)

Supplementary Video 3

(Movie showing full dataset from Fig. 5.) Intravital visualization of mutant and wildtype K6a expression in skin. The expression plasmids pUBC-K6a(WT)-EGFP (pTD239, a) or pUBC-K6a(N171K)-EGFP (pTD240, b) were intradermally injected (40 μg in 70 μL PBS) into mouse footpads and imaged (24 h). a WT K6a expression is generally uniformly expressed throughout the cytoplasm of each cell leaving a dark nuclear region in the center of each cell (arrows depict examples). b Mutant N171K K6a/EGFP expression results in pronounced (as compared to WT expression) aggregation. (AVI 3714 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hickerson, R.P., Speaker, T.J., Lara, M.F. et al. Non-Invasive Intravital Imaging of siRNA-Mediated Mutant Keratin Gene Repression in Skin. Mol Imaging Biol 18, 34–42 (2016). https://doi.org/10.1007/s11307-015-0875-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11307-015-0875-z

Key words

Navigation